Jump to content

Protease-activated receptor 2: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m →‎Agonists: + wiki link
→‎Agonists: ce; no longer so recent; + additional citation that also discloses PAR2 antagonists
Line 12: Line 12:
== Agonists ==
== Agonists ==


Recently, potent and selective [[small molecule]] [[agonist]]s for these receptors have also been discovered.<ref name="pmid18768780">{{cite journal | author = Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, Olsson R, Burstein ES | title = Identification and characterization of novel small-molecule protease-activated receptor 2 agonists | journal = J. Pharmacol. Exp. Ther. | volume = 327 | issue = 3 | pages = 799–808 | year = 2008 | month = December | pmid = 18768780 | doi = 10.1124/jpet.108.142570 }}</ref>
Potent and selective [[small molecule]] [[agonist]]s and [[receptor antagonist|antagonists]] for these receptors have been discovered.<ref name="pmid18768780">{{cite journal | author = Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, Olsson R, Burstein ES | title = Identification and characterization of novel small-molecule protease-activated receptor 2 agonists | journal = J. Pharmacol. Exp. Ther. | volume = 327 | issue = 3 | pages = 799–808 | year = 2008 | month = December | pmid = 18768780 | doi = 10.1124/jpet.108.142570 }}</ref><ref name="pmid20873792">{{cite journal | author = Barry GD, Suen JY, Le GT, Cotterell A, Reid RC, Fairlie DP | title = Novel agonists and antagonists for human protease activated receptor 2 | journal = J. Med. Chem. | volume = 53 | issue = 20 | pages = 7428–40 | year = 2010 | month = October | pmid = 20873792 | doi = 10.1021/jm100984y }}</ref>


==See also==
==See also==

Revision as of 06:30, 15 April 2012

Template:PBB Protease activated receptor 2 (PAR2) also known as coagulation factor II (thrombin) receptor-like 1 (F2RL1) or G-protein coupled receptor 11 (GPR11) is a protein that in humans is encoded by the F2RL1 gene. PAR2 modulates inflammatory responses and acts as a sensor for proteolytic enzymes generated during infection.[1]

Gene

The F2RL1 gene contains two exons and is widely expressed in human tissues. The predicted protein sequence is 83% identical to the mouse receptor sequence.[2]

Mechanism of activation

PAR2 is a member of the large family of 7-transmembrane receptors that couple to guanosine-nucleotide-binding proteins. PAR2 is also a member of the protease-activated receptor family. It is activated by trypsin, but not by thrombin. It is activated by proteolytic cleavage of its extracellular amino terminus. The new amino terminus functions as a tethered ligand and activates the receptor. Additionally, these receptors can be activated by exogenous proteases, such as house dust mite protein Der P9.[3] These receptors can also be activated non-protealytically, by exogenous peptide sequences that mimic the final amino acids of the tethered ligand.[4]

Agonists

Potent and selective small molecule agonists and antagonists for these receptors have been discovered.[5][6]

See also

References

  1. ^ Lee SE, Jeong SK, Lee SH (2010). "Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis". Yonsei Med. J. 51 (6): 808–22. doi:10.3349/ymj.2010.51.6.808. PMC 2995962. PMID 20879045. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. ^ "Entrez Gene: F2RL1 coagulation factor II (thrombin) receptor-like 1".
  3. ^ Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S (2001). "Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells". J. Immunol. 167 (2): 1014–21. PMID 11441110. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  4. ^ Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M, Sekiguchi F, Kubo S, Kuroda R, Iwaki M, Katsura K, Plevin R (2004). "Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo". J. Pharmacol. Exp. Ther. 309 (3): 1098–107. doi:10.1124/jpet.103.061010. PMID 14976227. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, Olsson R, Burstein ES (2008). "Identification and characterization of novel small-molecule protease-activated receptor 2 agonists". J. Pharmacol. Exp. Ther. 327 (3): 799–808. doi:10.1124/jpet.108.142570. PMID 18768780. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ Barry GD, Suen JY, Le GT, Cotterell A, Reid RC, Fairlie DP (2010). "Novel agonists and antagonists for human protease activated receptor 2". J. Med. Chem. 53 (20): 7428–40. doi:10.1021/jm100984y. PMID 20873792. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.